97 related articles for article (PubMed ID: 3014927)
21. Field observations during the bluetongue serotype 8 epidemic in 2006. I. Detection of first outbreaks and clinical signs in sheep and cattle in Belgium, France and the Netherlands.
Elbers AR; Backx A; Meroc E; Gerbier G; Staubach C; Hendrickx G; van der Spek A; Mintiens K
Prev Vet Med; 2008 Oct; 87(1-2):21-30. PubMed ID: 18620767
[TBL] [Abstract][Full Text] [Related]
22. A monovalent attenuated serotype 2 bluetongue virus vaccine confers homologous protection in sheep.
Hunter P; Modumo J
Onderstepoort J Vet Res; 2001 Dec; 68(4):331-3. PubMed ID: 12026066
[TBL] [Abstract][Full Text] [Related]
23. Bluetongue virus serotype 20 infections in cattle of breeding age.
Groocock CM; Parsonson IM; Campbell CH
Am J Vet Res; 1983 Sep; 44(9):1765-8. PubMed ID: 6312855
[TBL] [Abstract][Full Text] [Related]
24. A DIVA system based on the detection of antibodies to non-structural protein 3 (NS3) of bluetongue virus.
Barros SC; Cruz B; Luís TM; Ramos F; Fagulha T; Duarte M; Henriques M; Fevereiro M
Vet Microbiol; 2009 Jun; 137(3-4):252-9. PubMed ID: 19233575
[TBL] [Abstract][Full Text] [Related]
25. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep.
Boone JD; Balasuriya UB; Karaca K; Audonnet JC; Yao J; He L; Nordgren R; Monaco F; Savini G; Gardner IA; Maclachlan NJ
Vaccine; 2007 Jan; 25(4):672-8. PubMed ID: 17059856
[TBL] [Abstract][Full Text] [Related]
26. Differentiation between field and vaccine strain of bluetongue virus serotype 16.
Monaco F; Cammà C; Serini S; Savini G
Vet Microbiol; 2006 Aug; 116(1-3):45-52. PubMed ID: 16713688
[TBL] [Abstract][Full Text] [Related]
27. Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines.
González JM; Figueras L; Ortega ME; Lozano M; de Arcaute MR; Royo R; Cebrián LM; Ferrer LM; Fariñas F; de Jalón JA; De las Heras M
Vet Rec; 2010 Jun; 166(24):757-8. PubMed ID: 20543167
[No Abstract] [Full Text] [Related]
28. Importance of ovine cytotoxic T cells in protection against bluetongue virus infection.
Jeggo MH; Wardley RC; Brownlie J
Prog Clin Biol Res; 1985; 178():477-87. PubMed ID: 2989889
[TBL] [Abstract][Full Text] [Related]
29. Study of the safety and efficacy of a recombinant vaccine for bluetongue virus serotype 2.
Savini G; Nicolussi P; Pilo G; Colorito P; Fresi S; Teodori L; Leone A; Bonfini B; Patta C
Vet Ital; 2007; 43(4):807-20. PubMed ID: 20422560
[TBL] [Abstract][Full Text] [Related]
30. Bluetongue virus in pregnant elk and their calves.
Stott JL; Lauerman LH; Luedke AJ
Am J Vet Res; 1982 Mar; 43(3):423-8. PubMed ID: 6280527
[TBL] [Abstract][Full Text] [Related]
31. A study of the role of cell-mediated immunity in bluetongue virus infection in sheep, using cellular adoptive transfer techniques.
Jeggo MH; Wardley RC; Brownlie J
Immunology; 1984 Jul; 52(3):403-10. PubMed ID: 6086501
[TBL] [Abstract][Full Text] [Related]
32. Function of prostaglandins, thromboxane A2, and histamine in hypersensitivity reaction to experimental bluetongue disease in calves.
Emau P; Giri SN; Anderson GA; Stott JL; Osburn BI
Am J Vet Res; 1984 Sep; 45(9):1852-7. PubMed ID: 6093650
[TBL] [Abstract][Full Text] [Related]
33. Experimentally induced infection with bluetongue virus serotype 11 in cows.
Parsonson IM; Thompson LH; Walton TE
Am J Vet Res; 1994 Nov; 55(11):1529-34. PubMed ID: 7879975
[TBL] [Abstract][Full Text] [Related]
34. Effect of an inactivated bluetongue serotype 8 vaccine on semen quality in rams.
Leemans J; Raes M; Saegerman C; Sustronck B; Makoschey B; Kirschvink N
Vet J; 2012 Aug; 193(2):567-9. PubMed ID: 22365834
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of bluetongue virus expression in leukocytes from experimentally infected ruminants.
Ellis JA; Coen ML; MacLachlan NJ; Wilson WC; Williams ES; Leudke AJ
Am J Vet Res; 1993 Sep; 54(9):1452-6. PubMed ID: 8239132
[TBL] [Abstract][Full Text] [Related]
36. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
37. Bluetongue vaccines: the past, present and future.
Bhanuprakash V; Indrani BK; Hosamani M; Balamurugan V; Singh RK
Expert Rev Vaccines; 2009 Feb; 8(2):191-204. PubMed ID: 19196199
[TBL] [Abstract][Full Text] [Related]
38. [Vaccination against bluetongue serotype 8 in the Netherlands].
Kuijk H; Jansen M; Moulin V; Makoschey B
Tijdschr Diergeneeskd; 2008 Dec; 133(23):1006-9. PubMed ID: 19133439
[No Abstract] [Full Text] [Related]
39. Vaccination in the control of bluetongue in endemic regions: the South African experience.
Dungu B; Potgieter C; Von Teichman B; Smit T
Dev Biol (Basel); 2004; 119():463-72. PubMed ID: 15742661
[TBL] [Abstract][Full Text] [Related]
40. Neural changes in vaccinated calves challenge exposed with virulent infectious bovine rhinotracheitis virus.
Narita M; Inui S; Nanba K; Shimizu Y
Am J Vet Res; 1980 Dec; 41(12):1995-9. PubMed ID: 6259976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
